TAYLOR ALTUN: Open Payments
NPI 1801580477 · PALM SPRINGS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$524 in 27 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $210 · 2025 $524
Food & beverage: $524
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 7 | $141 |
| Gilead Sciences, Inc. | 3 | $63 |
| Regeneron Healthcare Solutions, Inc. | 3 | $63 |
| Ardelyx, Inc. | 2 | $47 |
| ABBVIE INC. | 2 | $43 |
| Janssen Biotech, Inc. | 2 | $40 |
| Aimmune Therapeutics, Inc. | 2 | $34 |
| Alnylam Pharmaceuticals Inc. | 1 | $29 |
| Intercept Pharmaceuticals, Inc. | 1 | $27 |
| Braintree Laboratories, Inc. | 1 | $26 |
Products named: REZDIFFRA, DUPIXENT, IBSRELA, MAVYRET, TREMFYA, VOWST, GIVLAARI, OCALIVA.
Industry payments across CA — which companies pay providers there.
